Pacira BioSciences Inc

XNAS: PCRX

Turnaround Potential

Download real time

25.20 -0.25 (-0.98%)

125.81% Gain from 52W Low

680.5K XNAS Volume

XNAS 23 Apr, 2025 5:30 PM (EDT)

1,166.2

Market Cap

Below industry Median

0.3

Beta 1Year

Very Low volatility

Pacira BioSciences Inc - PCRX - stock price prediction, stock price target, analyst ratings from 7 analysts

Pacira BioSciences Inc has a share price target of US$ 36, revenue growth forecast of 7.4%, and profit growth estimate of 152.9% for FY25, based on top 7 analyst calls.

Forecaster Screeners